Trade-Ideas: Ironwood Pharmaceuticals (IRWD) Is Today's

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Trade-Ideas LLC identified Ironwood Pharmaceuticals ( IRWD) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified Ironwood Pharmaceuticals as such a stock due to the following factors:

  • IRWD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $23.5 million.
  • IRWD has traded 128,148 shares today.
  • IRWD is up 3.3% today.
  • IRWD was down 9.4% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in IRWD with the Ticky from Trade-Ideas. See the FREE profile for IRWD NOW at Trade-Ideas

More details on IRWD:

Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. Currently there are 5 analysts that rate Ironwood Pharmaceuticals a buy, 1 analyst rates it a sell, and 4 rate it a hold.

The average volume for Ironwood Pharmaceuticals has been 1.3 million shares per day over the past 30 days. Ironwood has a market cap of $1.8 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.10 and a short float of 17.3% with 7.79 days to cover. Shares are up 27.9% year-to-date as of the close of trading on Tuesday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Ironwood Shares Jump on FDA Approval for Hyperuricemia Drug - Biotech Movers

5 Ways Allergan Can Keep Up Momentum

Premarket Biotech Movers: Ironwood Pharmaceuticals, Rigel Pharmaceuticals, FibroGen

Synergy Pharmaceuticals Secures Approval for Linzess Competitor

Ironwood Pharmaceuticals (IRWD): Today's Weak On High Volume Stock